Page last updated: 2024-08-17

quinoxalines and Demyelinating Diseases

quinoxalines has been researched along with Demyelinating Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ali, C; Clemente, D; Correa, F; Docagne, F; Guaza, C; Hernangómez, M; Loría, F; Mestre, L; Muñetón, V; Vivien, D	1

Other Studies

1 other study(ies) available for quinoxalines and Demyelinating Diseases

Article	Year
Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation. Molecular and cellular neurosciences, 2007, Volume: 34, Issue:4 Topics: Animals; Blotting, Western; Cannabinoids; Demyelinating Diseases; Disease Models, Animal; Electrophoresis, Polyacrylamide Gel; Excitatory Amino Acid Antagonists; Female; Immunohistochemistry; Mice; Multiple Sclerosis, Chronic Progressive; Neuroprotective Agents; Quinoxalines; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Spinal Cord	2007

Article

Year

Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation.

Molecular and cellular neurosciences, 2007, Volume: 34, Issue:4

Topics: Animals; Blotting, Western; Cannabinoids; Demyelinating Diseases; Disease Models, Animal; Electrophoresis, Polyacrylamide Gel; Excitatory Amino Acid Antagonists; Female; Immunohistochemistry; Mice; Multiple Sclerosis, Chronic Progressive; Neuroprotective Agents; Quinoxalines; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Spinal Cord

2007